GSK Investigational Site

Hamden, Connecticut 06518

0 studies enrolling now · 10 studies all time

What they study most

Arthritis, Rheumatoid, Bipolar Disorder, Crohn's Disease, Depressive Disorder, Diabetes Mellitus, Type 2, Epilepsy, Major Depressive Disorder (MDD), Respiratory Syncytial Virus Infections

Studies at this site

• Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults — Completed
• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• Seasonal Affective Depression (SAD) Study — Completed
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Lethargic Depression Study — Completed
• COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis — Completed
• Rosiglitazone In Subjects With Type 2 Diabetes Mellitus Who Are Inadequately Controlled On Insulin — Completed
• Bipolar Study in Adults at Least 18 Years of Age — Completed